Trans-Labyrinthine Approach — A Comprehensive Account (50 Marks)

1. INTRODUCTION & HISTORICAL BACKGROUND

"The translabyrinthine approach provides wide and direct access to CPA tumors with minimal cerebellar retraction. The versatility of this approach for large and small tumors makes it the most common approach used in neurotologic surgery." — Cummings Otolaryngology Head and Neck Surgery

2. SURGICAL ANATOMY

Key Structures to Identify:

Diagram: Completed Translabyrinthine Exposure (from Cummings Otolaryngology)

3. INDICATIONS

Absolute Indications:

1. Acoustic neuroma (Vestibular schwannoma) — all sizes, especially medium-to-large (>2 cm), where hearing preservation is not anticipated
2. Small acoustic neuromas in patients with non-serviceable hearing (PTA >50 dB, SDS <50%)
3. CPA tumors with pre-operative hearing loss

Other Indications:

1. CPA meningiomas, non-acoustic neuromas, gliomas, chordomas
2. Skull base chondrosarcomas
3. Facial nerve decompression — total facial nerve exposure (from IAC to stylomastoid foramen) in:
   • Transverse temporal bone fractures
   • Extensive facial neuromas
   • Large congenital cholesteatomas extending into IAC
4. Vestibular neurectomy (when hearing is non-serviceable)
5. Nerve grafting requiring wide working space near brainstem

"This technique is ideal for removal of medium-sized and large acoustic neuromas because hearing preservation is unlikely by any approach in tumors larger than 2 cm and because this approach carries the highest rate of preservation of facial nerve function." — Cummings

4. CONTRAINDICATIONS

1. Serviceable hearing in the operative ear — hearing preservation approaches (middle fossa, retrosigmoid) preferred
2. Solitary hearing ear
3. Active mastoid infection
4. Medically unfit patient (relative)
5. Tumor extension requiring retrosigmoid or middle fossa approach (relative)

5. PRE-OPERATIVE ASSESSMENT

Clinical Evaluation:

• Complete audiological assessment: Pure tone audiometry (PTA), speech discrimination score (SDS)
• Caloric testing / VEMP — vestibular function
• Facial nerve function: House-Brackmann grading pre-operatively

Imaging:

• Gadolinium-enhanced MRI — gold standard for CPA/IAC lesions (enhancing mass)
• HRCT temporal bone — bony anatomy, extent of pneumatisation, jugular bulb position, sigmoid sinus position

Classification of Hearing (Gardner-Robertson / AAO-HNS):

• Class A/B = serviceable hearing → hearing preservation approach
• Class C/D = non-serviceable hearing → translabyrinthine approach

Other Pre-operative Steps:

• Informed consent (hearing loss is permanent and expected)
• Abdominal fat graft site preparation
• Intraoperative facial nerve monitoring setup (EMG electrodes to orbicularis oris and oculi)
• Pre-operative antibiotics

6. SURGICAL TECHNIQUE — STEP BY STEP

Patient Positioning:

• Supine position, head turned to opposite side, neck slightly extended
• Head-holding pins NOT used
• Draping includes lower left abdominal quadrant for fat harvest

Incision:

• Curved postauricular incision with apex 3 cm posterior to the postauricular crease
• Carried inferiorly over the mastoid tip
• Soft tissue and periosteum elevated from mastoid cortex to EAC, exposing occipital bone posterior to sigmoid sinus
• Self-retaining retractors inserted

BONE REMOVAL — FOUR STAGES:

Performed with operating microscope + high-speed drill + continuous suction-irrigation. Cutting burs for most drilling; diamond burs near dura and venous sinuses.

Stage 1 — Complete Mastoidectomy:

• Cortical mastoidectomy performed
• Sigmoid sinus skeletonized posteriorly
• Bone removed posterior to sigmoid sinus (extent depends on tumor size — greater removal = greater CPA exposure)
• Middle fossa plate identified and thinned superiorly
• Facial nerve identified in its vertical (mastoid) segment — covered with thin bone shell for protection
• Mastoid emissary vein transected; bleeding controlled with sutures/cautery/bone wax

Stage 2 — Complete Labyrinthectomy:

• Horizontal, superior (anterior), and posterior semicircular canals systematically removed
• ⚠️ Caution at inferior border of horizontal canal — facial nerve proximity
• ⚠️ Caution at amputated end of posterior canal — lies medial to facial nerve
• Endolymphatic sac identified inferior to posterior semicircular canal
• Jugular bulb decompressed inferiorly

Stage 3 — Decompression of IAC and Dura:

• Bone overlying posterior fossa removed — "Bill's Island" (island of bone over sigmoid sinus can be left)
• Petrous ridge (junction between middle fossa dura and posterior fossa dura) removed
• Superior petrosal sinus controlled with bipolar cautery or oxidized cellulose strips
• Bone removed 180° around the IAC — from porus acusticus to fundus
• At lateral end of IAC:
  • Facial nerve found anterior and superior (medial to Bill's bar)
  • Superior vestibular nerve found posterior to Bill's bar
  • Transverse crest separates superior and inferior vestibular nerves

Stage 4 — Tumor/Lesion Removal:

• Dura opened over IAC and CPA (T-shaped or linear incision)
• Tumor dissection begins at lateral end of IAC to identify facial nerve early
• Facial nerve identified and maintained throughout; continuous EMG monitoring
• Tumor debulked internally before capsule dissection
• CPA exposure allows visualization of brainstem, CN VII, and CN VIII
• Facial nerve stimulated at brainstem to confirm continuity
• Hemostasis achieved; CSF leak controlled

CLOSURE:

1. Dural defect covered with temporalis fascia
2. Fascia draped over aditus to separate mastoid from middle ear
3. Eustachian tube packed with fascia and muscle to prevent CSF otorrhinorrhoea
4. Mastoid space obliterated with abdominal fat graft
5. Hydroxyapatite cement or titanium mesh may be used for additional cranioplasty
6. Wound closed in layers; compressive mastoid dressing applied

7. FLOWCHART: DECISION TO TRANSLABYRINTHINE APPROACH

PATIENT WITH CPA/IAC LESION
         │
         ▼
AUDIOLOGICAL ASSESSMENT
(PTA + SDS)
         │
   ┌─────┴─────┐
   │           │
Serviceable   Non-Serviceable
Hearing       Hearing (or Large
(Class A/B)   Tumor >2 cm, Class C/D)
   │           │
   │           ▼
   │    TRANSLABYRINTHINE APPROACH
   │           │
   ▼           ▼
Middle Fossa  Supine positioning, postauricular incision
or             │
Retrosigmoid   ▼
Approach      Stage 1: Complete Mastoidectomy
              + Skeletonise sigmoid sinus
               │
               ▼
              Stage 2: Complete Labyrinthectomy
              (Remove all 3 SCCs)
               │
               ▼
              Stage 3: IAC + Dura Decompression
              (180° around IAC; identify Bill's bar)
               │
               ▼
              Stage 4: Dural Opening + Tumour Removal
              (Facial nerve identification first)
               │
               ▼
              CLOSURE
              (Temporalis fascia + Abdominal fat + HA cement)

8. FLOWCHART: INTRAOPERATIVE FACIAL NERVE MANAGEMENT

Pre-op: EMG electrodes placed (orbicularis oris + oculi)
         │
         ▼
Stage 1: Identify vertical segment of CN VII in mastoid
(keep bony shell, do NOT expose nerve)
         │
         ▼
Stage 2: Labyrinthectomy — protect inferior border of LSCC
and amputated end of PSCC (both near facial nerve)
         │
         ▼
Stage 3: At fundus of IAC
   → Bill's bar: CN VII anterior-superior
   → Superior vestibular nerve: posterior to Bill's bar
         │
         ▼
Dural Opening — start dissection at LATERAL IAC
(facial nerve identified before tumor manipulation)
         │
         ▼
Tumour dissection with continuous EMG monitoring
         │
    ┌────┴────┐
    │         │
Nerve intact  Nerve damaged/transected
    │         │
    ▼         ▼
Closure    Cable graft (greater auricular
           or sural nerve)
           or end-to-end anastomosis
           near brainstem

9. ADVANTAGES

1. Direct, wide access to CPA and IAC without cerebellar retraction
2. Early facial nerve identification at the fundus of IAC — highest rate of facial nerve preservation of all CPA approaches
3. No brain retraction required — minimal cerebellar manipulation
4. Versatility — suitable for all tumor sizes; the most commonly used neurotologic approach
5. Allows total facial nerve exposure in a single approach (from brainstem to stylomastoid foramen)
6. Adequate working space for interpositional nerve grafting near brainstem
7. No risk of meningitis from opening of mastoid air cells (as with retrosigmoid)
8. Suitable for unfavorable vascular anatomy (high jugular bulb, anteriorly placed sigmoid sinus) with wide decompression

10. DISADVANTAGES

1. Irreversible hearing loss — cochlear and vestibular function are permanently destroyed
2. Technically demanding — requires neurotologic/skull base expertise
3. Risk of CSF leak (managed by fat obliteration + ET packing)
4. Risk of sigmoid sinus injury
5. Restricted anterior exposure compared to transcochlear/transotic approaches

"The disadvantage of the translabyrinthine approach is that hearing cannot be preserved." — Cummings Otolaryngology

11. COMPARISON WITH OTHER CPA APPROACHES

12. COMPLICATIONS

Intraoperative:

• Sigmoid sinus injury → venous air embolism, haemorrhage
• Facial nerve injury
• CSF leak
• Jugular bulb injury

Early Postoperative:

• CSF leak — most common serious complication; through wound or nose/ear
  • Management: bed rest, lumbar drain, re-exploration if persistent
• Meningitis (bacterial or aseptic)
• Facial nerve paresis/paralysis
• Haematoma

Late:

• Persistent CSF leak
• Meningocoele / pseudomeningocoele
• Recurrence of tumour (incomplete removal)
• Chronic headache
• Epidermoid inclusion cyst

13. POSTOPERATIVE MANAGEMENT

• Head of bed elevated 30°
• Mastoid compressive dressing for 5–7 days
• IV antibiotics for 24–48 hours
• Close monitoring of facial nerve function (House-Brackmann grading daily)
• CSF leak watch — monitor for watery nasal discharge or wound leak
• Vestibular physiotherapy early — to promote vestibular compensation
• Audiological rehabilitation planning (cochlear implant discussed if bilateral or single hearing ear)
• Follow-up MRI at 6 months, then annually for 5 years

"Osmotic agents and diuretics for brain relaxation usually are not used in the translabyrinthine approach; however, the retrolabyrinthine, retrosigmoid, middle fossa, and extended middle fossa approaches require such techniques." — Cummings

14. MODIFICATIONS OF THE TRANSLABYRINTHINE APPROACH

a) Retrolabyrinthine Approach:

• Preserves labyrinth; access posterior to it
• Limited CPA exposure; no access to lateral IAC
• Used for: vestibular neurectomy with preserved hearing, endolymphatic sac surgery

b) Transotic Approach (Fisch):

• Modification of TL — EAC closed, posterior EAC wall removed
• Facial nerve skeletonised but left in bony canal (not transposed)
• Greater anterior exposure than TL; access to clivus and jugular foramen
• Indication: CPA tumors extending into jugular foramen or clivus
• Advantage: avoids facial nerve transposition risk

c) Transcochlear Approach:

• Extends TL by removing cochlea + posterior transposing the facial nerve
• Provides access to petrous apex and petroclival junction
• Disadvantage: temporary facial paralysis uniform (due to devascularisation at geniculate ganglion)
• Limited use — only for life-threatening extensive lesions (malignancies, vertebrobasilar aneurysms)
• Recovery usually to HB Grade III-IV

d) Extended Translabyrinthine Approach:

• Greater posterior fossa bone removal
• For very large tumors with significant CPA extension

15. RECENT ADVANCES (RGUHS-relevant)

1. Endoscope-Assisted Translabyrinthine Surgery:

• Combined microscopic + endoscopic technique
• Angled endoscopes (30°, 45°) provide visualization around "corners" — fundus of IAC, anterior CPA
• Reduces residual tumor in hidden corners
• Enables fully endoscopic TL approach in select centres

2. Intraoperative Neuromonitoring (IONM):

• Continuous EMG (facial nerve) monitoring — standard of care
• Near-infrared spectroscopy (NIRS) monitoring
• Intraoperative ABR monitoring (though artifacts from drilling limit utility)
• Motor evoked potentials for brainstem-adjacent tumors

3. Simultaneous Cochlear Implantation:

• In patients undergoing TL removal of acoustic neuroma who desire auditory rehabilitation
• Cochlear implant inserted at time of TL surgery
• Auditory brainstem implant (ABI) — when cochlear nerve is not preserved
• Studies: DeHart et al., Cochlear implantation concurrent with TL acoustic neuroma resection (Laryngoscope 2003)

4. Hydroxyapatite Cement Cranioplasty:

• Replaces traditional fat-only obliteration
• Better obliteration of mastoid cavity → reduced CSF leak rate
• Arriaga MA et al.: Hydroxyapatite cement cranioplasty in TL acoustic neuroma surgery (Otolaryngol Head Neck Surg 2002)

5. Robotic Surgery:

• Robotic-assisted drilling in TL approach — experimental
• Aims to reduce surgeon fatigue, improve precision near facial nerve

6. Pre-operative Embolisation:

• For vascular CPA tumors (meningiomas) — reduces intraoperative blood loss

7. Gamma Knife / Stereotactic Radiosurgery:

• For residual/recurrent tumor post-TL surgery
• Salvage radiotherapy for small residual tumors at brainstem

8. Diffusion Tensor Imaging (DTI) / Tractography:

• Pre-operative mapping of facial nerve course through tumor
• Guides surgical strategy

16. SUMMARY TABLE — KEY MNEMONICS

17. REFERENCES FROM KEY TEXTBOOKS

1. Cummings Otolaryngology Head and Neck Surgery, 7th Ed. — Chapter 179 (Skull Base Surgery) and Chapter 173 (Facial Nerve). Elsevier, 2021.
2. K.J. Lee's Essential Otolaryngology, 11th Ed. — Chapter on Skull Base: Transotic and Translabyrinthine Approaches.
3. Scott-Brown's Otorhinolaryngology, Head and Neck Surgery, 8th Ed. — Neurotology section: CPA surgery.
4. Hazarika P — ENT: Head and Neck Surgery — Neurotology chapter, TL approach.
5. Dhingra PL — Diseases of Ear, Nose and Throat — Acoustic neuroma management.
6. Zakir Hussain — ENT for Postgraduates — Skull base approaches.
7. Stell and Maran's Otorhinolaryngology — Surgical approaches to CPA.
8. Arriaga MA et al.: Hydroxyapatite cement cranioplasty in translabyrinthine acoustic neuroma surgery. Otolaryngol Head Neck Surg 126:512, 2002.
9. DeHart AN et al.: Translabyrinthine vestibular schwannoma resection with simultaneous cochlear implantation. Cochlear Implants International, 2003.

Note on image generation: The generate_image tool (for creating new custom diagrams) has reached its monthly plan limit. The anatomical diagram above (Fig. 173.18 from Cummings) shows the completed translabyrinthine exposure with all key structures labelled. To access more custom diagrams, please upgrade your subscription plan.